SAGASAFE Trademark

Trademark Overview


On Thursday, March 5, 2020, a trademark application was filed for SAGASAFE with the United States Patent and Trademark Office. The USPTO has given the SAGASAFE trademark a serial number of 79295928. The federal status of this trademark filing is REGISTERED as of Tuesday, April 27, 2021. This trademark is owned by SAGA Diagnostics AB. The SAGASAFE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; diagnostic preparations and materials, namely, medical diagnostic reagents; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; clinical medical reagents; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic testing materials for medical use; genetic identity tests ...

Genetic counseling; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis being medical analysis for diagnostic and treatment of persons provided by medical laboratories; medical and healthcare services; medical monitoring of patients; stem cell therapy services; medical services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; medical consultancy and information services relating to medical products; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons relating to cancer and infectious diseases; medical analysis services for the diagnosis of cancer; medical analysis servic...

Analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research in the field of cancer and infectious diseases and medical research; clinical research in the field of cancer and infectious diseases; clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to laboratory testing; consultancy relating to pharmaceutical research and development; medical laboratory services; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating ...
sagasafe

General Information


Serial Number79295928
Word MarkSAGASAFE
Filing DateThursday, March 5, 2020
Status700 - REGISTERED
Status DateTuesday, April 27, 2021
Registration Number6331245
Registration DateTuesday, April 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements


Goods and ServicesNucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; diagnostic preparations and materials, namely, medical diagnostic reagents; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; clinical medical reagents; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic testing materials for medical use; genetic identity tests comprised of reagents for medical purposes; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for analysis of blood and other liquids; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; reactants for medical diagnosis being diagnostic reagents for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for blood grouping for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic pregnancy tests; veterinary diagnostic reagents
Pseudo MarkSAGA SAFE
Goods and ServicesGenetic counseling; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis being medical analysis for diagnostic and treatment of persons provided by medical laboratories; medical and healthcare services; medical monitoring of patients; stem cell therapy services; medical services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; medical consultancy and information services relating to medical products; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons relating to cancer and infectious diseases; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients relating to cancer and infectious diseases; medical analysis services relating to the treatment of persons for cancer and infectious diseases provided by a medical laboratory; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical and health services relating to DNA, genetics and genetic testing; medical care and analysis of cancer diagnosis relating to patient treatment; medical consultations; medical diagnostic services; medical evaluation services; medical analysis services for diagnostic and treatment purposes of blood samples taken from patients provided by medical laboratories; medical screening; medical services for the treatment of skin cancer; medical services in the field of oncology; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; prostate cancer screening services; providing cancer screening services; RNA or DNA analysis for cancer diagnosis and prognosis; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for the preparation of medical reports relating to health care; technical consultancy services relating to medical health; testicular cancer screening services
Goods and ServicesAnalysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research in the field of cancer and infectious diseases and medical research; clinical research in the field of cancer and infectious diseases; clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to laboratory testing; consultancy relating to pharmaceutical research and development; medical laboratory services; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating to medical and veterinary pharmaceutical and diagnostic research and development; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 16, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 16, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAGA Diagnostics AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE

Party NameSAGA Diagnostics AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE

Party NameSAGA Diagnostics AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events


Event DateEvent Description
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 15, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, August 29, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 9, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 9, 2021FINAL DISPOSITION PROCESSED
Tuesday, July 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 31, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 29, 2020REFUSAL PROCESSED BY IB
Thursday, November 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, November 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 13, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 12, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 12, 2020REFUSAL PROCESSED BY MPU
Thursday, October 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2020APPLICATION FILING RECEIPT MAILED
Friday, October 16, 2020ASSIGNED TO EXAMINER
Friday, October 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB